Ondansetron HCL 8 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FKC50
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,637
Award facts
- Contract value 100% obligated
- $38,636.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $38,636.92 on September 24, 2025, for Ondansetron HCL 8 mg tablets (30-count packaging). This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to the prime contractor. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 25, 2025. Ondansetron is a widely used antiemetic medication commonly prescribed to prevent nausea and vomiting, particularly in military and veteran healthcare settings.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that serves as a comprehensive pharmaceutical support vehicle for military healthcare worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies a broad portfolio of medications and medical supplies across multiple therapeutic domains to support Defense Health Agency operations, the U.S. Coast Guard, and other government healthcare systems. The company's extensive contract history with DLA demonstrates its capability to fulfill federal medical procurement requirements through open competition across both routine and specialized pharmaceutical needs.
Quick answers
Who was awarded contract SPE2DB25FKC50?
SPE2DB25FKC50 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FKC50 worth?
The government has obligated $38,637 on SPE2DB25FKC50.
Is contract SPE2DB25FKC50 an order under another contract?
Yes. SPE2DB25FKC50 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FKC50 competed?
The extent of competition for SPE2DB25FKC50 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award